Ibuprofen Gen.Orph

Ibuprofen, the active ingredient in Ibuprofen Gen.Orph, is a nonsteroidal anti-inflammatory drug presented as an intravenous solution for intravenous use. It provides analgesic, antipyretic, and anti‑inflammatory effects for adults experiencing acute pain, fever, or inflammatory conditions.

GNH USA supplies Ibuprofen Gen.Orph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and distributes the product to healthcare facilities across multiple continents.

Ibuprofen administered intravenously acts on the cyclooxygenase pathway to relieve pain, reduce inflammation, and lower fever.

- Pain: Provides rapid analgesia in acute postoperative or trauma‑related pain. - Inflammation: Decreases inflammatory response in musculoskeletal or postoperative swelling. - Fever: Lowers elevated body temperature in febrile patients.

Intravenous ibuprofen may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: transient feeling of sickness. - Headache: mild to moderate intensity. - Injection site pain: discomfort at the infusion site.

Serious or Rare Side Effects: - Gastrointestinal bleeding: potentially life‑threatening hemorrhage. - Severe allergic reaction (anaphylaxis): rapid onset of airway compromise. - Renal impairment: reduced kidney function, especially in at‑risk patients.

Prior to initiating therapy, clinicians should evaluate patient‑specific risk factors and follow safe handling practices. - Assess renal function: evaluate baseline creatinine before initiating therapy. - Monitor gastrointestinal risk: avoid in patients with active ulcers or bleeding. - Check cardiovascular status: use cautiously in patients with history of thrombotic disease. - Avoid use in late pregnancy: category D indicates potential fetal risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Ibuprofen can interact with several drug classes, requiring careful assessment of benefit versus risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: potentiates renal and gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function. - Diuretics: risk of electrolyte imbalance. - Lithium: ibuprofen can increase lithium levels, necessitating serum monitoring.